Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Liposomal gadolinium (GD) contrast agent “NMRX” for T1-MRI

Liposomal gadolinium (GD) contrast agent “NMRX” for T1-MRI

US Patent 11052162 · Granted Jul 6, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeting ligands for tau pathology2025
Dual mode gadolinium nanoparticle contrast agents2024
Targeted contrast agents for MRI of alpha-synuclein deposition2023
Targeted contrast agents for MRI of alpha-synuclein deposition2023
Targeting ligands for tau pathology2023
Systems and methods for application specific load balancing2022
Targeting nanoparticles2022
Targeting nanoparticles2022
Hydrophilic fluorinated molecules for liposomal 19F MRI probes with unique MR si2022
Hydrophilic fluorinated molecules for liposomal 19F MRI probes with unique MR si2022
MRI imaging of amyloid plaque using liposomes2021
MRI imaging of amyloid plaque using liposomes2021